These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24268099)

  • 41. Intensive short-term dynamic psychotherapy for DSM-IV personality disorders: a randomized controlled trial.
    Abbass A; Sheldon A; Gyra J; Kalpin A
    J Nerv Ment Dis; 2008 Mar; 196(3):211-6. PubMed ID: 18340256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment utilization by patients with personality disorders.
    Bender DS; Dolan RT; Skodol AE; Sanislow CA; Dyck IR; McGlashan TH; Shea MT; Zanarini MC; Oldham JM; Gunderson JG
    Am J Psychiatry; 2001 Feb; 158(2):295-302. PubMed ID: 11156814
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Day hospital mentalization-based treatment v. specialist treatment as usual in patients with borderline personality disorder: randomized controlled trial.
    Laurenssen EMP; Luyten P; Kikkert MJ; Westra D; Peen J; Soons MBJ; van Dam AM; van Broekhuyzen AJ; Blankers M; Busschbach JJV; Dekker JJM
    Psychol Med; 2018 Nov; 48(15):2522-2529. PubMed ID: 29478425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Latent classes of personality disorders: group comparisons and course of psychotherapy].
    Lange J; Schöttke H
    Psychother Psychosom Med Psychol; 2013 Sep; 63(9-10):365-73. PubMed ID: 23633117
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Psychosocial treatment for severe personality disorder. 36-month follow-up.
    Chiesa M; Fonagy P
    Br J Psychiatry; 2003 Oct; 183():356-62. PubMed ID: 14519615
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Out-patient psychotherapy for borderline personality disorder: cost-effectiveness of schema-focused therapy v. transference-focused psychotherapy.
    van Asselt AD; Dirksen CD; Arntz A; Giesen-Bloo JH; van Dyck R; Spinhoven P; van Tilburg W; Kremers IP; Nadort M; Severens JL
    Br J Psychiatry; 2008 Jun; 192(6):450-7. PubMed ID: 18515897
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An intervention for parents with severe personality difficulties whose children have mental health problems: a feasibility RCT.
    Day C; Briskman J; Crawford MJ; Foote L; Harris L; Boadu J; McCrone P; McMurran M; Michelson D; Moran P; Mosse L; Scott S; Stahl D; Ramchandani P; Weaver T
    Health Technol Assess; 2020 Mar; 24(14):1-188. PubMed ID: 32174297
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Group schema therapy versus group cognitive behavioral therapy for social anxiety disorder with comorbid avoidant personality disorder: study protocol for a randomized controlled trial.
    Baljé A; Greeven A; van Giezen A; Korrelboom K; Arntz A; Spinhoven P
    Trials; 2016 Oct; 17(1):487. PubMed ID: 27717405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: a cross-sectional study.
    Gumà-Uriel L; Peñarrubia-María MT; Cerdà-Lafont M; Cunillera-Puertolas O; Almeda-Ortega J; Fernández-Vergel R; García-Campayo J; Luciano JV
    BMC Fam Pract; 2016 Jun; 17():61. PubMed ID: 27245582
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prediction of medium-term outcome in cluster B personality disorder following residential and outpatient psychosocial treatment.
    Chiesa M; Fonagy P
    Psychother Psychosom; 2007; 76(6):347-53. PubMed ID: 17917470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.
    Capomolla S; Febo O; Ceresa M; Caporotondi A; Guazzotti G; La Rovere M; Ferrari M; Lenta F; Baldin S; Vaccarini C; Gnemmi M; Pinna G; Maestri R; Abelli P; Verdirosi S; Cobelli F
    J Am Coll Cardiol; 2002 Oct; 40(7):1259-66. PubMed ID: 12383573
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Day treatment of patients with personality disorders: experiences from a Norwegian treatment research network.
    Karterud S; Pedersen G; Bjordal E; Brabrand J; Friis S; Haaseth O; Haavaldsen G; Irion T; Leirvåg H; Tørum E; Urnes O
    J Pers Disord; 2003 Jun; 17(3):243-62. PubMed ID: 12839103
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The impact of comorbid depression on recovery from personality disorders and improvements in psychosocial functioning: results from a randomized controlled trial.
    Renner F; Bamelis LL; Huibers MJ; Speckens A; Arntz A
    Behav Res Ther; 2014 Dec; 63():55-62. PubMed ID: 25302762
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Favourable outcome of long-term combined psychotherapy for patients with borderline personality disorder: Six-year follow-up of a randomized study.
    Antonsen BT; Kvarstein EH; Urnes Ø; Hummelen B; Karterud S; Wilberg T
    Psychother Res; 2017 Jan; 27(1):51-63. PubMed ID: 26261865
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Mental health service utilization among borderline personality disorder patients inpatient].
    Cailhol L; Thalamas C; Garrido C; Birmes P; Lapeyre-Mestre M
    Encephale; 2015 Apr; 41(2):115-22. PubMed ID: 25526809
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effectiveness of outpatient, day hospital, and inpatient psychotherapeutic treatment for patients with cluster B personality disorders.
    Bartak A; Andrea H; Spreeuwenberg MD; Ziegler UM; Dekker J; Rossum BV; Hamers EF; Scholte W; Aerts J; Busschbach JJ; Verheul R; Stijnen T; Emmelkamp PM
    Psychother Psychosom; 2011; 80(1):28-38. PubMed ID: 20975324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Short-term intensive psychodynamic group therapy versus cognitive-behavioral group therapy in day treatment of anxiety disorders and comorbid depressive or personality disorders: study protocol for a randomized controlled trial.
    Suszek H; Holas P; Wyrzykowski T; Lorentzen S; Kokoszka A
    Trials; 2015 Jul; 16():319. PubMed ID: 26220089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The cost of borderline personality disorder: societal cost of illness in BPD-patients.
    van Asselt AD; Dirksen CD; Arntz A; Severens JL
    Eur Psychiatry; 2007 Sep; 22(6):354-61. PubMed ID: 17544636
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effective psychotherapy for personality disorders in the Netherlands: the value of further research and active implementation.
    Soeteman DI; Busschbach JJ; Verheul R; Hoomans T; Kim JJ
    Value Health; 2011; 14(2):229-39. PubMed ID: 21296601
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.